We are live on ! Find out more
WCBA

Weaver C. Barksdale & Associates Portfolio holdings

AUM $105M
1-Year Est. Return 13.81%
This Fund
S&P 500
This Quarter Est. Return
+2.68%
1 Year Est. Return
+13.81%
3 Year Est. Return
+40.08%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$104M
AUM Growth
-$256K
Cap. Flow
-$1.86M
Cap. Flow %
-1.78%
Top 10 Hldgs %
22.2%
Holding
64
New
2
Increased
1
Reduced
58
Closed
2

Top Buys

Rank Stock Value
1
AOS icon
A.O. Smith
AOS
+$1.99M
2
KMB icon
Kimberly-Clark
KMB
+$1.81M
3
MRK icon
Merck
MRK
+$348K

Top Sells

Rank Stock Value
1
UL icon
Unilever
UL
+$1.66M
2
TRP icon
TC Energy
TRP
+$1.36M
3
GILD icon
Gilead Sciences
GILD
+$258K
4
ORI icon
Old Republic International
ORI
+$258K
5
JPM icon
JPMorgan Chase
JPM
+$213K

Sector Composition

Rank Sector Weight
1 Financials 24.84%
2 Healthcare 14.89%
3 Industrials 12.89%
4 Consumer Staples 8.63%
5 Technology 8.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ORI icon
1
Old Republic International
ORI
$10.5B
$2.49M 2.39%
63,455
-7,031
-10% -$258K
AFL icon
2
Aflac
AFL
$64.9B
$2.43M 2.33%
21,884
-523
-2% -$55.5K
KR icon
3
Kroger
KR
$35.4B
$2.38M 2.28%
35,100
-852
-2% -$54K
GILD icon
4
Gilead Sciences
GILD
$162B
$2.37M 2.27%
21,150
-2,505
-11% -$258K
ABBV icon
5
AbbVie
ABBV
$443B
$2.34M 2.25%
11,180
-256
-2% -$49.8K
CINF icon
6
Cincinnati Financial
CINF
$27.3B
$2.3M 2.2%
15,563
-362
-2% -$51K
SCHW
7
Charles Schwab
SCHW
$183B
$2.28M 2.19%
29,145
-701
-2% -$55K
SNA icon
8
Snap-on
SNA
$21.2B
$2.21M 2.12%
6,572
-156
-2% -$53K
JPM icon
9
JPMorgan Chase
JPM
$935B
$2.19M 2.1%
8,914
-835
-9% -$213K
CMI icon
10
Cummins
CMI
$87.5B
$2.15M 2.06%
6,851
-164
-2% -$57.8K
PKG icon
11
Packaging Corp of America
PKG
$21.9B
$2.14M 2.06%
10,824
-256
-2% -$54.6K
UNM icon
12
Unum
UNM
$13.6B
$2.11M 2.02%
25,871
-617
-2% -$47.6K
AMP icon
13
Ameriprise Financial
AMP
$48.3B
$2.1M 2.02%
4,345
-104
-2% -$54.5K
AMGN icon
14
Amgen
AMGN
$208B
$2.07M 1.98%
6,636
-154
-2% -$45.5K
PRU icon
15
Prudential Financial
PRU
$42.4B
$2.06M 1.98%
18,482
-440
-2% -$50.1K
ELV icon
16
Elevance Health
ELV
$81.5B
$2.04M 1.96%
4,693
-110
-2% -$44.2K
GD icon
17
General Dynamics
GD
$104B
$2.03M 1.95%
7,453
-179
-2% -$46.5K
MET icon
18
MetLife
MET
$61.9B
$2.02M 1.94%
25,211
-599
-2% -$49.8K
NEE icon
19
NextEra Energy
NEE
$181B
$1.97M 1.89%
27,865
-670
-2% -$47.3K
LOW icon
20
Lowe's Companies
LOW
$117B
$1.95M 1.87%
8,375
-199
-2% -$49K
MSFT icon
21
Microsoft
MSFT
$3.45T
$1.94M 1.86%
5,167
-123
-2% -$50.1K
AOS icon
22
A.O. Smith
AOS
$8.29B
$1.92M 1.85%
+29,422
New +$1.99M
WTRG icon
23
Essential Utilities
WTRG
$11.3B
$1.91M 1.83%
48,360
-1,148
-2% -$42.2K
KMB icon
24
Kimberly-Clark
KMB
$36.3B
$1.91M 1.83%
+13,418
New +$1.81M
CVX icon
25
Chevron
CVX
$392B
$1.9M 1.82%
11,374
-270
-2% -$42.3K
1
2 3

Similar funds

EW
Expressive Wealth Chicago, Illinois $105M AUM
ANBOT
American National Bank of Texas Richardson, Texas $105M AUM
P
Palladiem Bryn Mawr, Pennsylvania $105M AUM
SPW
Signet Private Wealth Chicago, Illinois $105M AUM
SHF
Safe Harbor Fiduciary Pensacola, Florida $105M AUM
NS
Northland Securities Minneapolis, Minnesota $105M AUM
ACA
Alpha Capital Advisors Bangor, Maine $105M AUM
HA
Helium Advisors Everett, Washington $105M AUM 15.41% 1-Year Est. Return

Weaver C. Barksdale & Associates's Q1 2025 Portfolio in Review

As of Q1 2025, Weaver C. Barksdale & Associates held 64 positions worth $104M, down 0.24% from $104M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Weaver C. Barksdale & Associates's Q1 2025 filing shows 2 new, 1 increased, 58 reduced and 2 closed positions. Its largest new stake was A.O. Smith: 29,422 shares worth $1.92M. The largest sale was Unilever, an estimated $1.66M.

By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 25% a quarter earlier, followed by Healthcare and Industrials.

  • Weaver C. Barksdale & Associates's largest Q1 2025 buy was A.O. Smith: 29,422 shares worth $1.92M.
  • Weaver C. Barksdale & Associates added most to Merck in Q1 2025, an estimated $348K increase.
  • Weaver C. Barksdale & Associates's biggest Q1 2025 reduction was Gilead Sciences, cutting an estimated $258K.
  • Weaver C. Barksdale & Associates fully exited Unilever in Q1 2025, selling an estimated $1.66M.
  • Weaver C. Barksdale & Associates's ten largest holdings make up 22% of its $104M portfolio in Q1 2025.
  • Weaver C. Barksdale & Associates opened 2 new positions and closed 2 in Q1 2025.
  • Weaver C. Barksdale & Associates's portfolio value fell 0.24% quarter-over-quarter to $104M.

Based on Weaver C. Barksdale & Associates's 13F filing for Q1 2025, filed 14 May 2025.